Pulmonary resection in the treatment of patients with pulmonary multidrug-resistant tuberculosis in taiwan

C. Y. Chiang, M. C. Yu, K. J. Bai, J. Suo, T. P. Lin, Y. C. Lee

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

SETTING: Chronic Disease Control Bureau, Department of Health, Taiwan. OBJECTIVE: To evaluate the role of pulmonary resection in the treatment of pulmonary tuberculosis resistant to isoniazid and rifampin (MDR-TB). DESIGN: In a retrospective cohort study, 27 MDR-TB patients who underwent pulmonary resection between December 1990 and March 1999 were reviewed. Individually-tailored treatment regimens were selected at a once-weekly staff conference following review of the patient's case history and drug susceptibility results. Surgery was performed for selected patients, essentially those: 1) whose medical treatment had failed, or for whom treatment failure seemed highly likely, or for whom post-treatment relapse seemed likely, 2) with predominantly localised disease, 3) with adequate cardiopulmonary reserve, and 4) whose treatment regimen had been composed of at least two effective drugs to diminish the mycobacterial burden. RESULTS: There was no surgical mortality apart from one peri-operative death (4%). Three patients (11%) developed complications, and 24 (92%) patients demonstrated sputum conversion and/or remained negative after surgery. Twenty-three patients have already completed treatment, and during a mean of 42 ± 18 follow-up months (range 15-80 months), one patient relapsed. This patient was disease-free after another course of treatment. CONCLUSION: For selected patients, pulmonary resection may improve the outcome of pulmonary MDR-TB.

Original languageEnglish
Pages (from-to)272-277
Number of pages6
JournalInternational Journal of Tuberculosis and Lung Disease
Volume5
Issue number3
Publication statusPublished - 2001
Externally publishedYes

Fingerprint

Multidrug-Resistant Tuberculosis
Taiwan
Pulmonary Tuberculosis
Lung
Therapeutics
Isoniazid
Rifampin
Sputum
Treatment Failure
Pharmaceutical Preparations
Chronic Disease
Cohort Studies
Retrospective Studies
Recurrence
Mortality

Keywords

  • Multidrug-resistant
  • Pulmonary resection
  • Surgery
  • Taiwan
  • Tuberculosis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

@article{9f1dba396e7448009cdb5ed921b6519d,
title = "Pulmonary resection in the treatment of patients with pulmonary multidrug-resistant tuberculosis in taiwan",
abstract = "SETTING: Chronic Disease Control Bureau, Department of Health, Taiwan. OBJECTIVE: To evaluate the role of pulmonary resection in the treatment of pulmonary tuberculosis resistant to isoniazid and rifampin (MDR-TB). DESIGN: In a retrospective cohort study, 27 MDR-TB patients who underwent pulmonary resection between December 1990 and March 1999 were reviewed. Individually-tailored treatment regimens were selected at a once-weekly staff conference following review of the patient's case history and drug susceptibility results. Surgery was performed for selected patients, essentially those: 1) whose medical treatment had failed, or for whom treatment failure seemed highly likely, or for whom post-treatment relapse seemed likely, 2) with predominantly localised disease, 3) with adequate cardiopulmonary reserve, and 4) whose treatment regimen had been composed of at least two effective drugs to diminish the mycobacterial burden. RESULTS: There was no surgical mortality apart from one peri-operative death (4{\%}). Three patients (11{\%}) developed complications, and 24 (92{\%}) patients demonstrated sputum conversion and/or remained negative after surgery. Twenty-three patients have already completed treatment, and during a mean of 42 ± 18 follow-up months (range 15-80 months), one patient relapsed. This patient was disease-free after another course of treatment. CONCLUSION: For selected patients, pulmonary resection may improve the outcome of pulmonary MDR-TB.",
keywords = "Multidrug-resistant, Pulmonary resection, Surgery, Taiwan, Tuberculosis",
author = "Chiang, {C. Y.} and Yu, {M. C.} and Bai, {K. J.} and J. Suo and Lin, {T. P.} and Lee, {Y. C.}",
year = "2001",
language = "English",
volume = "5",
pages = "272--277",
journal = "International Journal of Tuberculosis and Lung Disease",
issn = "1027-3719",
publisher = "International Union against Tubercul. and Lung Dis.",
number = "3",

}

TY - JOUR

T1 - Pulmonary resection in the treatment of patients with pulmonary multidrug-resistant tuberculosis in taiwan

AU - Chiang, C. Y.

AU - Yu, M. C.

AU - Bai, K. J.

AU - Suo, J.

AU - Lin, T. P.

AU - Lee, Y. C.

PY - 2001

Y1 - 2001

N2 - SETTING: Chronic Disease Control Bureau, Department of Health, Taiwan. OBJECTIVE: To evaluate the role of pulmonary resection in the treatment of pulmonary tuberculosis resistant to isoniazid and rifampin (MDR-TB). DESIGN: In a retrospective cohort study, 27 MDR-TB patients who underwent pulmonary resection between December 1990 and March 1999 were reviewed. Individually-tailored treatment regimens were selected at a once-weekly staff conference following review of the patient's case history and drug susceptibility results. Surgery was performed for selected patients, essentially those: 1) whose medical treatment had failed, or for whom treatment failure seemed highly likely, or for whom post-treatment relapse seemed likely, 2) with predominantly localised disease, 3) with adequate cardiopulmonary reserve, and 4) whose treatment regimen had been composed of at least two effective drugs to diminish the mycobacterial burden. RESULTS: There was no surgical mortality apart from one peri-operative death (4%). Three patients (11%) developed complications, and 24 (92%) patients demonstrated sputum conversion and/or remained negative after surgery. Twenty-three patients have already completed treatment, and during a mean of 42 ± 18 follow-up months (range 15-80 months), one patient relapsed. This patient was disease-free after another course of treatment. CONCLUSION: For selected patients, pulmonary resection may improve the outcome of pulmonary MDR-TB.

AB - SETTING: Chronic Disease Control Bureau, Department of Health, Taiwan. OBJECTIVE: To evaluate the role of pulmonary resection in the treatment of pulmonary tuberculosis resistant to isoniazid and rifampin (MDR-TB). DESIGN: In a retrospective cohort study, 27 MDR-TB patients who underwent pulmonary resection between December 1990 and March 1999 were reviewed. Individually-tailored treatment regimens were selected at a once-weekly staff conference following review of the patient's case history and drug susceptibility results. Surgery was performed for selected patients, essentially those: 1) whose medical treatment had failed, or for whom treatment failure seemed highly likely, or for whom post-treatment relapse seemed likely, 2) with predominantly localised disease, 3) with adequate cardiopulmonary reserve, and 4) whose treatment regimen had been composed of at least two effective drugs to diminish the mycobacterial burden. RESULTS: There was no surgical mortality apart from one peri-operative death (4%). Three patients (11%) developed complications, and 24 (92%) patients demonstrated sputum conversion and/or remained negative after surgery. Twenty-three patients have already completed treatment, and during a mean of 42 ± 18 follow-up months (range 15-80 months), one patient relapsed. This patient was disease-free after another course of treatment. CONCLUSION: For selected patients, pulmonary resection may improve the outcome of pulmonary MDR-TB.

KW - Multidrug-resistant

KW - Pulmonary resection

KW - Surgery

KW - Taiwan

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=0035035155&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035035155&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 272

EP - 277

JO - International Journal of Tuberculosis and Lung Disease

JF - International Journal of Tuberculosis and Lung Disease

SN - 1027-3719

IS - 3

ER -